ASTHMAPOC
Financiado
Disposable nitric oxide POC point of care test for home care easy management o...
Disposable nitric oxide POC point of care test for home care easy management of asthma in chronic patients
The ultimate goal we seek in ASTHMAPOC project is to develop a ready to the market point-of-care disposable device for self-patient management of chronic asthma. According to WHO statistics more than 235 million people suffer from...
The ultimate goal we seek in ASTHMAPOC project is to develop a ready to the market point-of-care disposable device for self-patient management of chronic asthma. According to WHO statistics more than 235 million people suffer from asthma worldwide. As for all other chronic diseases, effective management of asthma is full of challenges because of the difficulties in determining the appropriate treatment programs and the low adherence to control medications. This typically results in many patients non-effectively prevented from asthma exacerbations and the consequent unnecessary too often visits to emergencies. ASTHMAPOC aims providing a low-cost affordable solution to chronic asthmatic patients for self-management of their disease. Patients who self-test can have a better control over their chronic condition, and make therapeutic, behavioral, and environmental adjustments in accordance with advice from healthcare professionals.
Our approach to achieve ASTHMAPOC goals is to develop a point-of-care device based on disposable electrochemical biosensors capable to determine the concentration of FENO (fractional exhaled nitric oxide). FENO emerged in the last decade as an important biomarker for asthma assessment and management. The clinical utility of FENO has been already validated to the extent that currently there are approved standards in US and EU (further details will be provided in section 1.3). However, only few point-of-care devices have been developed for clinical use (section 1.4), while there is no single product for self-patient management in the market. This niche market is the one we seek exploring with ASTHMAPOC, but in order to be successful in this market we need first to carry out an in-depth feasibility study.
ver más
Duración del proyecto: 4 meses
Fecha Inicio: 2014-09-26
Fecha Fin: 2015-01-31
Fecha Fin: 2015-01-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2015-01-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
TECNOLOGIAS AVANZADAS INSPIRALIA
La realizacion de todo tipo de actividades de consultoria. el objeto social de la compañía es la realización de todo tipo de actividades de...
Perfil tecnológico
TRL
4-5
226K
Perfil tecnológico
TRL
4-5
226K